Peixian Mao
Biographic Data
| ID | 7954455 |
|---|---|
| NAME | Peixian Mao |
| GIVEN NAMES | Peixian |
| FAMILY NAME | Mao |
| SIGNATURE | MAO P |
| AFFILIATIONS | Beijing Anding Hospital |
| VERIFIED | No |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 5 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Unveiling chiral amino acid alterations and glycine dysregulation in late-life depression through targeted metabolomics
These findings underscore the importance of accounting for amino acid chirality in biomarker research and highlight chiral amino acids as promising candidates for the diagnosis of LLD and the prediction of treatment response
Executive function deficits and medial temporal lobe atrophy in late-life depression and Alzheimer’s disease: A comparative study
AD patients experience more severe EFD and MTA than LLD patients. The differential diagnosis of AD and LLD can be aided by the useful tool known as TMT. It is important to acknowledge that TMT is capable of capturing only a fraction of the executive function, thus necessitating a cautious interpretation of research findings
The cognitive effects of adjunctive repetitive transcranial magnetic stimulation for late-onset depression: A randomized controlled trial with 4 week follow-up
Treatment with 120% MT rTMS was associated with improvement in cognitive defects related to the active phase of LOD. These findings suggest that rTMS could provide early improvements in cognitive function in clinical settings for elderly patients with LOD. Clinical trial registration : https://www.chictr.org.cn/showproj.html?proj=40698, identifier ChiCTR1900024445
Prediction of Antidepressant Efficacy by Cognitive Function in First-Episode Late-Life Depression: A Pilot Study
[www.ClinicalTrials.gov], identifier [ChiCTR2100042370]
Altered Intrinsic Brain Activity in Patients With Late-Life Depression: A Resting-State Functional MRI Study
The changes of PerAF in the bilateral Frontal_Sup_Orb and bilateral ACC are related to an increased risk of developing LLD. Moreover, the PerAF method could be used as an underlying sensitivity biomarker to identify the psychiatric disorder
No prominent works on this page.
Prediction of Antidepressant Efficacy by Cognitive Function in First-Episode Late-Life Depression: A Pilot Study
[www.ClinicalTrials.gov], identifier [ChiCTR2100042370]
Altered Intrinsic Brain Activity in Patients With Late-Life Depression: A Resting-State Functional MRI Study
The changes of PerAF in the bilateral Frontal_Sup_Orb and bilateral ACC are related to an increased risk of developing LLD. Moreover, the PerAF method could be used as an underlying sensitivity biomarker to identify the psychiatric disorder
Executive function deficits and medial temporal lobe atrophy in late-life depression and Alzheimer’s disease: A comparative study
AD patients experience more severe EFD and MTA than LLD patients. The differential diagnosis of AD and LLD can be aided by the useful tool known as TMT. It is important to acknowledge that TMT is capable of capturing only a fraction of the executive function, thus necessitating a cautious interpretation of research findings
The cognitive effects of adjunctive repetitive transcranial magnetic stimulation for late-onset depression: A randomized controlled trial with 4 week follow-up
Treatment with 120% MT rTMS was associated with improvement in cognitive defects related to the active phase of LOD. These findings suggest that rTMS could provide early improvements in cognitive function in clinical settings for elderly patients with LOD. Clinical trial registration : https://www.chictr.org.cn/showproj.html?proj=40698, identifier ChiCTR1900024445
Unveiling chiral amino acid alterations and glycine dysregulation in late-life depression through targeted metabolomics
These findings underscore the importance of accounting for amino acid chirality in biomarker research and highlight chiral amino acids as promising candidates for the diagnosis of LLD and the prediction of treatment response
Cognition (5 works) · Depression (economics (5 works) · Medicine (5 works) · Psychology (5 works) · Functional Brain Connectivity Studies (4 works) · Internal Medicine (4 works) · Neuropsychology (4 works) · Psychiatry (4 works) · Late life depression (3 works) · Repeatable Battery for the Assessment of Neuropsychological Status (3 works)